Regulation 215 Prescribing and administration by supplementary prescribers

(1)

A supplementary prescriber (“S”) may not give a prescription for a prescription only medicine unless S meets conditions A and C.

(2)

A supplementary prescriber (“S”) may not—

(a)

parenterally administer a prescription only medicine; or

(b)

give directions for the parenteral administration of a prescription only medicine,

unless S meets conditions B and C.

(3)

Condition A is that S is acting in accordance with the terms of a clinical management plan that—

(a)

relates to the patient to whom the product is prescribed;

(b)

has effect when the prescription is given; and

(c)

includes the particulars specified in Schedule 14.

(4)

Condition B is that S is acting in accordance with the terms of a clinical management plan that—

(a)

relates to the patient to whom the product is, or is to be, administered;

(b)

has effect when the product is administered or (as the case may be) the direction is given; and

(c)

includes the particulars specified in Schedule 14.

(5)

Condition C is that S has access to health records that—

(a)

are the health records of the patient to whom the plan relates; and

(b)

are used by any doctor or dentist who is a party to the plan.

(6)

This regulation is subject to regulation 216.

(7)

In this regulation—

“clinical management plan” means a written plan (which may be amended from time to time) relating to the treatment of an individual patient agreed by—
1. (a)
  the patient to whom the plan relates;
2. (b)
  the doctor or dentist who is a party to the plan; and
3. (c)
  any supplementary prescriber who is to prescribe, give directions for administration or administer under the plan;
“health record” has the meaning given by section 68(2) of the Data Protection Act 1998 M1.

Annotations

C1: Pt. 12 modified (E.W.) (1.10.2015) by The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015 (S.I. 2015/895), regs. 1(3), 4(2)